UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 226

Sortiert nach

Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2013-10, Vol.145 (4), p.758-765.e2

2013

Volltextzugriff (PDF)

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2011-11, Vol.141 (5), p.1621-1628.e5

2011

Volltextzugriff (PDF)

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Gastroenterology (New York, N.Y. 1943), 2012, Vol.142 (1), p.63-70.e5

2012

Volltextzugriff (PDF)

Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study

Gut, 2014-03, Vol.63 (3), p.423-432

2014

Volltextzugriff (PDF)

Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis

The New England journal of medicine, 2011-11, Vol.365 (19), p.1781-1789

2011

Volltextzugriff (PDF)

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

The Lancet (British edition), 2012-12, Vol.380 (9857), p.1909-1915

2012

Volltextzugriff (PDF)

Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease

Clinical gastroenterology and hepatology, 2014-03, Vol.12 (3), p.423-431.e1

2014

Volltextzugriff (PDF)

Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease

Clinical gastroenterology and hepatology, 2013-08, Vol.11 (8), p.982-987

2013

Volltextzugriff (PDF)

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2006-04, Vol.130 (4), p.1054-1061

2006

Volltextzugriff (PDF)

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease

Inflammatory bowel diseases, 2012-11, Vol.18 (11), p.2063-2071

2012

Volltextzugriff (PDF)

The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study

The American journal of gastroenterology, 2009-08, Vol.104 (8), p.2080-2088

2009

Volltextzugriff (PDF)

Long‐term outcome of treatment with infliximab in pediatric‐onset Crohn's disease: A population‐based study

Inflammatory bowel diseases, 2011-10, Vol.17 (10), p.2144-2152

2011

Volltextzugriff (PDF)

Noninvasive Diagnosis of Large Esophageal Varices by Fibroscan: Strong Influence of the Cirrhosis Etiology

Alcoholism, clinical and experimental research, 2010-07, Vol.34 (7), p.1146-1153

2010

Volltextzugriff (PDF)

Absorption of Unconjugated Bile Acids from the Perfused Jejunum of the Anesthetized Rat: Structure–Activity Relationships and Rate‐Limiting Steps

Lipids, 2018-05, Vol.53 (5), p.465-468

2018

Volltextzugriff (PDF)

Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population‐Based Study in Northern France (1988‐1999)

Journal of pediatric gastroenterology and nutrition, 2005-07, Vol.41 (1), p.49-55

2005

Volltextzugriff (PDF)

Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn's Disease: A Pilot Study (ACROHNEM)

Journal of clinical medicine, 2020-01, Vol.9 (1), p.41

2020

Volltextzugriff (PDF)

Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease

The American journal of gastroenterology, 2016-05, Vol.111 (5), p.748-749

2016

Volltextzugriff (PDF)

Clinical predictors at diagnosis of disabling pediatric Crohn's disease

Inflammatory bowel diseases, 2012-11, Vol.18 (11), p.2072-2078

2012

Volltextzugriff (PDF)

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2018-04, Vol.154 (5), p.1334-1342.e4

2018

Volltextzugriff (PDF)

Is Stenting as “a Bridge to Surgery” an Oncologically Safe Strategy for the Management of Acute, Left-Sided, Malignant, Colonic Obstruction? A Comparative Study With a Propensity Score Analysis

Annals of surgery, 2013-07, Vol.258 (1), p.107-115

2013

Volltextzugriff (PDF)

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

Gut, 2015-02, Vol.64 (2), p.243-249

2015

Volltextzugriff (PDF)

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease

Inflammatory bowel diseases, 2014-06, Vol.20 (6), p.978-986

2014

Volltextzugriff (PDF)

A simple biological score for predicting low risk of short‐term relapse in Crohn's disease

Inflammatory bowel diseases, 2006-07, Vol.12 (7), p.551-557

2006

Volltextzugriff (PDF)

Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review

Inflammatory bowel diseases, 2017-05, Vol.23 (5), p.712-720

2017

Volltextzugriff (PDF)

Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice

Journal of gastroenterology and hepatology, 2009-11, Vol.24 (11), p.1745-1752

2009

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(201)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Life Sciences & Biomedicine
(111)
Humans
(101)
Gastroenterology & Hepatology
(90)
Male
(73)
Female
(67)
Adult
(54)
Gastroenterology And Hepatology
(48)
Life Sciences
(46)
Middle Aged
(42)
Biological And Medical Sciences
(35)
Medical Sciences
(33)
Aged
(28)
Gastroenterology. Liver. Pancreas. Abdomen
(27)
Other Diseases. Semiology
(24)
Adolescent
(23)
Inflammatory Bowel Disease
(22)
Prospective Studies
(21)
Treatment Outcome
(21)
Follow-Up Studies
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study

Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease

Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease

The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study

Long‐term outcome of treatment with infliximab in pediatric‐onset Crohn's disease: A population‐based study

Noninvasive Diagnosis of Large Esophageal Varices by Fibroscan: Strong Influence of the Cirrhosis Etiology

Absorption of Unconjugated Bile Acids from the Perfused Jejunum of the Anesthetized Rat: Structure–Activity Relationships and Rate‐Limiting Steps

Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population‐Based Study in Northern France (1988‐1999)

Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn's Disease: A Pilot Study (ACROHNEM)

Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease

Clinical predictors at diagnosis of disabling pediatric Crohn's disease

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

Is Stenting as “a Bridge to Surgery” an Oncologically Safe Strategy for the Management of Acute, Left-Sided, Malignant, Colonic Obstruction? A Comparative Study With a Propensity Score Analysis

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease

A simple biological score for predicting low risk of short‐term relapse in Crohn's disease

Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review

Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice

Suchergebnisse filtern